Cellular mechanisms of tumour suppression by the retinoblastoma gene

Burkhart, Deborah L., Sage, Julien·2008·Nature Reviews Cancer
DOI 10.1038/nrc2399

Cited by (975)

Items 101–200 of 975

  1. Targeting cell cycle and hormone receptor pathways in cancer
    Clay E.S. Comstock, Michael A. Augello, Jonathan F. Goodwin, Renée de Leeuw, Matthew Joseph Schiewer, William F. Ostrander, Richard Andrew Burkhart, A. Kathleen McClendon, Peter A. McCue, Edouard John Trabulsi et al. · 2013 · Oncogene
  2. Pan-cancer molecular analysis of the RB tumor suppressor pathway
    Erik S. Knudsen, Ram Nambiar, Spencer R. Rosario, Dominic J. Smiraglia, David W. Goodrich, Agnieszka Katarzyna Witkiewicz · 2020 · Communications Biology
  3. Targeting nucleocytoplasmic transport in cancer therapy
    Richard Hill, Bastien Cautain, Nuria de Pedro, Wolfgang Link · 2013 · Oncotarget
  4. E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis
    Tongpeng Xu, Yan-Fen Wang, Weiliang Xiong, Pei Ma, Wenyu Wang, Wenming Chen, Mingde Huang, Rui Xia, Rong Wang, Erbao Zhang et al. · 2017 · Cell Death and Disease
  5. RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis
    Mu‐En Wang, Jiaqi Chen, Yi Lu, Alyssa R. Bawcom, Jinjin Wu, Jianhong Ou, John M. Asara, Andrew J. Armstrong, Qianben Wang, Lei Li et al. · 2023 · Journal of Clinical Investigation
  6. Cell Cycle–Targeted Cancer Therapies
    Charles J. Sherr, Jiří Bártek · 2016 · Annual Review of Cancer Biology
  7. From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells
    Niels van Nieuwenhuijzen, Ingrid Spaan, Reinier A P Raymakers, Victor Peperzak · 2018 · Cancer Research
  8. Tumour suppressor genes in chemotherapeutic drug response
    Dulcie Lai, Stacy Grieve, Xiaolong Yang · 2012 · Bioscience Reports
  9. Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions
    Navjotsingh Pabla, Alice A. Gibson, Mike Buege, Su Sien Ong, Lie Li, Shuiying Hu, Guoqing Du, Jason A. Sprowl, Aksana Vasilyeva, Laura J. Janke et al. · 2015 · Proceedings of the National Academy of Sciences
  10. Mechanism-Based Screen for G1/S Checkpoint Activators Identifies a Selective Activator of EIF2AK3/PERK Signalling
    Simon R. Stockwell, Georgina Platt, S. Elaine Barrie, Georgia Zoumpoulidou, Robert te Poele, G. Wynne Aherne, Stuart C. Wilson, Peter W. Sheldrake, Edward McDonald, Mathilde Venet et al. · 2012 · PLoS ONE
  11. HMGA molecular network: From transcriptional regulation to chromatin remodeling
    Riccardo Sgarra, Salvina Zammitti, Alessandra Lo Sardo, Elisa Maurizio, Laura Arnoldo, Silvia Pegoraro, Vincenzo Giancotti, Guidalberto Manfioletti · 2009 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  12. A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib
    Qing-Yun Chong, Ze Hui Kok, Ngoc-Linh-Chi Bui, Xiaoqiang Xiang, Andrea Li‐Ann Wong, Wei Peng Yong, Gautam Sethi, Peter Edward Lobie, Lingzhi Wang, Boon-Cher Goh · 2020 · Pharmacological Research
  13. The antitumor activity of the fungicide ciclopirox
    Hongyu Zhou, Tao Shen, Yan Luo, Lei Liu, Wenxing Chen, Baoshan Xu, Xiuzhen Han, Jia Pang, Chantal A. Rivera, Shile Huang · 2010 · International Journal of Cancer
  14. Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt
    Jinfang Zhang, Kai Lin Xu, Pengda Liu, Yan Geng, Bin Wang, Wenjian Gan, Jianping Guo, Fei Wu, Y. Rebecca Chin, Christian J. Berrios et al. · 2016 · Molecular Cell
  15. Differential gene expression profile of retinoblastoma compared to normal retina.
    Arupa A. Ganguly, Carol L. Shields · 2010 · PubMed Central
  16. The Hallmarks of Cancer from a Redox Perspective
    Marten Hornsveld, Tobias B. Dansen · 2016 · Antioxidants and Redox Signaling
  17. Cryptotanshinone Inhibits Cancer Cell Proliferation by Suppressing Mammalian Target of Rapamycin–Mediated Cyclin D1 Expression and Rb Phosphorylation
    Wenxing Chen, Yan Luo, Lei Liu, Hongyu Zhou, Baoshan Xu, Xiuzhen Han, Tao Shen, Zhijun Liu, Yin Lu, Shile Huang · 2010 · Cancer Prevention Research
  18. Differential impact of RB status on E2F1 reprogramming in human cancer
    Christopher M. McNair, Kexin Xu, Amy C. Mandigo, Matteo Benelli, Benjamin E. Leiby, Daniel Nava Rodrigues, Johan Lindberg, Henrik Grönberg, Mateus Crespo, Bram De Laere et al. · 2017 · Journal of Clinical Investigation
  19. Regulation of Adipocyte Differentiation via MicroRNAs
    You Hwa Son, Sojeong Ka, Ayoung Kim, Jae Bum Kim · 2014 · Endocrinology and Metabolism
  20. Emerging roles of RETINOBLASTOMA-RELATED proteins in evolution and plant development
    Ruben Gutzat, Lorenzo Borghi, Wilhelm Gruissem · 2012 · Trends in Plant Science
  21. Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer
    Agnieszka Katarzyna Witkiewicz, Sejin Chung, Rachel Brough, Paris J. Vail, Jorge Franco, Christopher J. Lord, Erik S. Knudsen · 2018 · Cell Reports
  22. Proliferation and Apoptosis Pathways and Factors in Oral Squamous Cell Carcinoma
    Steven He, Rajdeep Chakraborty, Shoba Ranganathan · 2022 · International Journal of Molecular Sciences
  23. Attenuation of the Retinoblastoma Pathway in Pancreatic Neuroendocrine Tumors Due to Increased Cdk4/Cdk6
    Laura H. Tang, Tanupriya Contractor, Richard Clausen, David S. Klimstra, Yi‐Chieh Nancy Du, Peter J. Allen, Murray F. Brennan, Arnold J. Levine, Chris R. Harris · 2012 · Clinical Cancer Research
  24. Transcriptional regulation of cellular senescence
    Lanigan, F, Geraghty, J G, Bracken, A P · 2011 · Oncogene
  25. A Double-Edged Sword: How Oncogenes and Tumor Suppressor Genes Can Contribute to Chromosomal Instability
    Bernardo Orr, Duane A. Compton · 2013 · Frontiers in Oncology
  26. Ink4‐Arf locus in cancer and aging
    Charles J. Sherr · 2012 · Wiley Interdisciplinary Reviews Developmental Biology
  27. Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset
    Christopher A. Febres‐Aldana, Jason C. Chang, Ryan N. Ptashkin, Yuhan Wang, Erika Gedvilaite, Marina K. Baine, William David Travis, Katia Ventura, Francis M. Bodd, Helena Alexandra Yu et al. · 2022 · Clinical Cancer Research
  28. Hutchinson–Gilford progeria syndrome through the lens of transcription
    Miron Prokocimer, Rachel Barkan, Yosef Gruenbaum · 2013 · Aging Cell
  29. Single-molecule emulsion PCR in microfluidic droplets
    Zhi Zhu, Gareth N. Jenkins, Wenhua Zhang, Mingxia Zhang, Zhichao Guan, Chaoyong James Yang · 2012 · Analytical and Bioanalytical Chemistry
  30. Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer
    Renée de Leeuw, Lisa D. Berman-Booty, Matthew Joseph Schiewer, Stephen J. Ciment, Robert Benjamin Den, Adam Paul Dicker, William Kevin Kelly, Edouard John Trabulsi, Costas D. Lallas, Leonard G. Gomella et al. · 2015 · Clinical Cancer Research
  31. Emerging roles of RB family: New defense mechanisms against tumor progression
    Paola Indovina, Eleonora Marcelli, Nadia Casini, Valeria Rizzo, Antonio Giordano · 2012 · Journal of Cellular Physiology
  32. The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells
    Albert Gubern, Manel Joaquin, Miriam Marqués, Pedro Maseres, Javier Garcı́a-Garcı́a, Ramon Amat, Daniel González-Nuñez, Baldomero Oliva, Francisco X. Real, Eulàlia de Nadal et al. · 2016 · Molecular Cell
  33. Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications
    Huidan Tan, Shouyue Zhang, Jin Zhang, Lingjuan Zhu, Yanmei Chen, Hongmei Yang, Yi Chen, Yang An, Bo Liu · 2020 · Theranostics
  34. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
    Balbina García-Reyes, Anna-Laura Kretz, Jan-Philipp Ruff, Silvia von Karstedt, Andreas Hillenbrand, Uwe Knippschild, Doris Henne‐Bruns, Johannes Lemke · 2018 · International Journal of Molecular Sciences
  35. Mutation profile of non-small cell lung cancer revealed by next generation sequencing
    Ya‐Sian Chang, Siang-Jyun Tu, Yu‐Chia Chen, Ting‐Yuan Liu, Ya-Ting Lee, Ju-Chen Yen, Hsin‐Yuan Fang, Jan‐Gowth Chang · 2021 · Respiratory Research
  36. RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs
    Tyler Robinson, Jeff C. Liu, Frederick S. Vizeacoumar, Thomas Sun, Neil MacLean, Sean E. Egan, Aaron David Schimmer, Alessandro Datti, Eldad Zacksenhaus · 2013 · PLoS ONE
  37. Promising roles of mammalian E2Fs in hepatocellular carcinoma
    Lei Zhan, Cheng Huang, Xiao‐Ming Meng, Yang Song, Xiao Qin Wu, Cheng Gui Miu, Xiang Shu Zhan, Jun Li · 2014 · Cellular Signalling
  38. Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation
    Donald J. Vander Griend, Ivan V. Litvinov, John T. Isaacs · 2014 · International Journal of Biological Sciences
  39. Skp2 Deletion Unmasks a p27 Safeguard that Blocks Tumorigenesis in the Absence of pRb and p53 Tumor Suppressors
    Hongling Zhao, Frederick Bauzon, Hao Fu, Zhonglei Lu, Jinhua Cui, Keiko Nakayama, Keiichi I. Nakayama, Joseph D. Locker, Liang Zhu · 2013 · Cancer Cell
  40. Regulation of the retinoblastoma proteins by the human herpesviruses
    Adam J. Hume, Robert F. Kalejta · 2009 · Cell Division
  41. Small cell lung cancer: Subtypes and therapeutic implications
    Walter Wang, Alyssa Shulman, Joseph M. Amann, David Paul Carbone, Philip N. Tsichlis · 2022 · Seminars in Cancer Biology
  42. Newly identified aspects of tumor suppression by RB
    Patrick Viatour, Julien Sage · 2011 · Disease Models & Mechanisms
  43. pRB, a tumor suppressor with a stabilizing presence
    Amity L. Manning, Nicholas J. Dyson · 2011 · Trends in Cell Biology
  44. In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis
    Srividya Vaidyanathan, Kathleen Cato, L Tang, Sandra J. Pavey, Nikolas K. Haass, Brian G. Gabrielli, Pascal H. G. Duijf · 2016 · Oncogene
  45. Update on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma
    Jolieke G. van Oosterwijk, Jakob Anninga, Hans A. J. Gelderblom, Anne‐Marie Cleton-Jansen, Judith V.M.G. Bovée · 2013 · Hematology/Oncology Clinics of North America
  46. Walls around tumours — why plants do not develop cancer
    John H. Doonan, Robert W. M. Sablowski · 2010 · Nature reviews. Cancer
  47. Aldolase A promotes proliferation and G 1 /S transition via the EGFR/MAPK pathway in non‐small cell lung cancer
    Hailu Fu, Huijun Gao, Xiaoyu Qi, Lei Zhao, Donghua Wu, Yuxin Bai, Huimin Li, Xuan Liu, Jun X. Hu, Shujuan Shao · 2018 · 癌症：英文版
  48. Restriction point regulation at the crossroads between quiescence and cell proliferation
    Betheney R. Pennycook, Alexis R. Barr · 2020 · FEBS Letters
  49. PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein
    Caiyun Grace Li, Jennifer E. Nyman, Antony W. Braithwaite, Michael Roger Eccles · 2011 · Oncogene
  50. The SNF2‐like helicase HELLS mediates E2F3‐dependent transcription and cellular transformation
    Björn von Eyß, Jonas Maaskola, Sebastian Memczak, Katharina Möllmann, Anja Schuetz, Christoph Loddenkemper, Mai-Dinh Tanh, Albrecht Otto, Kathrin Muegge, Udo Heinemann et al. · 2011 · The EMBO Journal
  51. RNA polymerase III transcription in cancer: the BRF2 connection
    Stephanie Cabarcas‐Petroski, Laura Schramm · 2011 · Molecular Cancer
  52. Molecular Oncology of Breast Cancer
    Himanshu N. Joshi, Michael F. Press · 2017 · Elsevier eBooks
  53. Network calisthenics
    Jeffrey V. Wong, Peng Dong, Joseph R. Nevins, Bernard Mathey-Prévôt, Lingchong You · 2011 · Cell Cycle
  54. Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation
    Maya Kansara, Huei San Leong, Dan Lin, Sophie Popkiss, Puiyi Pang, Dale W. Garsed, Carl R. Walkley, Carleen M. Cullinane, Jason Ellul, Nicole M. Haynes et al. · 2013 · Journal of Clinical Investigation
  55. FoxM1 Regulates Mammary Luminal Cell Fate
    Janai R. Carr, Megan M. Kiefer, Hyun Jung Park, Jing Li, Zebin Wang, Joel Fontanarosa, Danielle DeWaal, Dragana Kopanja, Elizaveta V. Benevolenskaya, Grace Guzman et al. · 2012 · Cell Reports
  56. CDK8 kinase—An emerging target in targeted cancer therapy
    Tomasz Rzymski, Michał Mikuła, Katarzyna Wiklik, Krzysztof D. Brzózka · 2015 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  57. Feedback regulation in cell signalling: Lessons for cancer therapeutics
    Lan K. Nguyen, Boris Ν. Kholodenko · 2015 · Seminars in Cell and Developmental Biology
  58. The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1/CDK2/cyclin E1 complex
    Mingyi Zhou, Zhuo Yang, Danbo Wang, Peng Chen, Yong Zhang · 2021 · Journal of Experimental & Clinical Cancer Research
  59. Deletion of Rb Accelerates Pancreatic Carcinogenesis by Oncogenic Kras and Impairs Senescence in Premalignant Lesions
    Catherine Carrière, A. Jesse Gore, Alixanna M. Norris, Jason R. Gunn, Alison L. Young, Daniel S. Longnecker, Murray Korc · 2011 · Gastroenterology
  60. DNA replication stress differentially regulates G1/S genes via Rad53‐dependent inactivation of Nrm1
    Anna Travesa, Dwight Kuo, Robertus A.M. de Bruin, Tatyana I. Kalashnikova, Marisela Guaderrama, Kevin Eric Thai, Aaron Aslanian, Marcus Bustamante Smolka, John R. Yates, Trey E. Ideker et al. · 2012 · The EMBO Journal
  61. Autophagy regulation in cancer development and therapy.
    Erin J. White, Vanesa Martı́n, Juinn-Lin Liu, Sarah R. Klein, Sujan Piya, Candelaria Gomez‐Manzano, Juan Fueyo-Margareto, Hong Jiang · 2011 · Europe PMC (PubMed Central)
  62. Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapy
    Knijnenburg, Theo A., Klau, Gunnar W., Iorio, Francesco, Garnett, Mathew J., McDermott, Ultan, Shmulevich, Ilya, Wessels, Lodewyk F. A. · 2016 · Scientific Reports
  63. Infection-specific phosphorylation of glutamyl-prolyl tRNA synthetase induces antiviral immunity
    Lee, Eun-Young, Lee, Hyun-Cheol, Kim, Hyun-Kwan, Jang, Song Yee, Park, Seong-Jun, Kim, Yong-Hoon, Kim, Jong Hwan, Hwang, Jungwon, Kim, Jae-Hoon, Kim, Tae-Hwan et al. · 2016 · Nature Immunology
  64. YAP1‐LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis
    Chunbo He, Xiangmin Lv, Cong Huang, Guohua Hua, Bowen Ma, Xingcheng Chen, Peter C. Angeletti, Jixin Dong, Jin Rong Zhou, Zhengfeng Wang et al. · 2019 · EMBO Reports
  65. Antitumor Drugs and Their Targets
    Zlatko Dembić · 2020 · Molecules
  66. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer
    Ji Yun Lee, Kyunghee Park, Hae Su Kim, Hae Su Kim, Kwai Han Yoo, Ki Sun Jung, Min Eui Hong, Mineui Hong, In‐Gu Do, TaeJin Ahn et al. · 2015 · Oncotarget
  67. Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide
    Deborah Biasoli, Suzana Assad Kahn, T A Cornélio, Milena Bastos Furtado, Loraine Campanati, Hervé Chneiweiss, Vivaldo Moura‐Neto, Helena L. Borges · 2013 · Cell Death and Disease
  68. Upregulated miR‐106a plays an oncogenic role in pancreatic cancer
    Pei Li, Qinhong Xu, Dong Zhang, Xuqi Li, Liang Han, Jianjun Lei, Wanxing Duan, Qingyong Ma, Zheng Wu, Zheng Wang · 2014 · FEBS Letters
  69. Sarcomas in hereditary retinoblastoma
    Ruth A. Kleinerman, Sara J. Schonfeld, Margaret Anne Tucker · 2012 · Clinical Sarcoma Research
  70. Lineage factors and differentiation states in lung cancer progression
    William K.C. Cheung, Don X. Nguyen · 2015 · Oncogene
  71. RB-Pathway Disruption Is Associated with Improved Response to Neoadjuvant Chemotherapy in Breast Cancer
    Agnieszka Katarzyna Witkiewicz, Adam Ertel, Jeanne M. McFalls, Matias Emanuel Valsecchi, Gordon Francis Schwartz, Erik S. Knudsen · 2012 · Clinical Cancer Research
  72. Repression of Germline RNAi Pathways in Somatic Cells by Retinoblastoma Pathway Chromatin Complexes
    Xiaoyun Wu, Zhen Shi, Mingxue Cui, Min Han, Gary Ruvkun · 2012 · PLoS Genetics
  73. Targeting RB1 Loss in Cancers
    Paing Linn, Susumu Kohno, Jindan Sheng, Nilakshi Kulathunga, Hai Yu, Zhiheng Zhang, Dominic Chih‐Cheng Voon, Yoshihiro Watanabe, Chiaki Takahashi · 2021 · Cancers
  74. Tumor suppressors: enhancers or suppressors of regeneration?
    Jason H. Pomerantz, Helen M. Blau · 2013 · Development
  75. Posttranslational Modifications of the Retinoblastoma Tumor Suppressor Protein as Determinants of Function
    James I. MacDonald, Frederick A. Dick · 2012 · Genes & Cancer
  76. Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expression
    Phillip M. Garfin, Dullei Min, Jerrod L. Bryson, Thomas F. Serwold, Badreddin Edris, Clare C. Blackburn, Ellen Rothman Richie, Kenneth I. Weinberg, Nancy Ruth Manley, Julien Sage et al. · 2013 · The Journal of Experimental Medicine
  77. Markers of cellular senescence.
    Carnero, Amancio · 2013 · Methods in Molecular Biology
  78. Cyclin D–CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB
    Amy E. Schade, Matthew G. Oser, Hilary Elaine Nicholson, James A. DeCaprio · 2019 · Oncogene
  79. Epigenetic memory and cell fate reprogramming in plants
    Kenneth D. Birnbaum, François Roudier · 2016 · Regeneration
  80. Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma
    Sachdeva, Uma M., O’Brien, Joan M. · 2012 · Journal of Clinical Investigation
  81. RB1 mutations and second primary malignancies after hereditary retinoblastoma
    Charlotte J. Dommering, Tamara Marees, Annemarie H. van der Hout, Saskia Marijke Imhof, Hanne E.J. Meijers-Heijboer, Peter J. Ringens, Flora E. van Leeuwen, Annette C. Moll · 2011 · Familial Cancer
  82. Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions
    Vazquez-Martin, Alejandro, López-Bonetc, Eugeni, Cufí, Sílvia, Oliveras-Ferraros, Cristina, Del Barco, Sonia, Martin-Castillo, Begoña, Menendez, Javier A. · 2011 · Drug Resistance Updates
  83. Possible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent?
    Kasra Jahankhani, F. Ahangari, I. Adcock, E. Mortaz · 2023 · Biochimie
  84. Analysis of Gene Expression Profiling in Meningioma: Deregulated Signaling Pathways Associated with Meningioma and EGFL6 Overexpression in Benign Meningioma Tissue and Serum
    Xuanchun Wang, Ye Gong, Daijun Wang, Qing Mei Xie, Mingzhe Zheng, Yu Zhou, Qin Li, Zhen Hua Yang, Hailiang Tang, Yiming Li et al. · 2012 · PLoS ONE
  85. The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system
    Kay F. Macleod · 2008 · Nature reviews. Cancer
  86. Illuminating Cancer Systems with Genetically Engineered Mouse Models and Coupled Luciferase ReportersIn Vivo
    Brandon A. Kocher, David R Piwnica-Worms · 2013 · Cancer Discovery
  87. Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma
    Lelliott, Emily J., McArthur, Grant A., Oliaro, Jane, Sheppard, Karen E. · 2021 · Frontiers in Immunology
  88. Toward precision medicine of breast cancer
    Nicolas Carels, Lizânia Borges Spinassé, Tatiana Martins Tilli, Jack A. Tuszyński · 2016 · Theoretical Biology and Medical Modelling
  89. Recruitment of Pontin/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression
    Amy Tarangelo, Nathanael Lo, Rebecca Siew Yan Teng, Eunsun Kim, Linh Le, Deborah J. Watson, Emma Elizabeth Furth, Pichai Raman, Ursula Ehmer, Patrick Viatour · 2015 · Nature Communications
  90. E2F1: a promising regulator in ovarian carcinoma
    Lei Zhan, Yu Zhang, Wenyan Wang, Enxue Song, Yijun Fan, Bing Wei · 2016 · Tumor Biology
  91. Post-translational modifications on the retinoblastoma protein
    Linbin Zhou, Danny Siu‐Chun Ng, Jason C. S. Yam, Li Jia Chen, Clement Chee Yung Tham, Chi Pui Pang, Wai Kit Chu · 2022 · Journal of Biomedical Science
  92. Targeting CDK4/6 in breast cancer
    Anusha Shanabag, Jessica Armand, Eugene Son, Hee Won Yang · 2025 · Experimental & Molecular Medicine
  93. Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27Kip1 ubiquitination pathway in hepatocellular carcinoma
    Haidong Xu, Chungyoul Choe, Seung–Hun Shin, Sung‐Won Park, Ho‐Shik Kim, Seung‐Hyun Jung, Seon‐Hee Yim, Tae‐Min Kim, Yeun‐Jun Chung · 2014 · Experimental & Molecular Medicine
  94. Regulation of theChlamydomonasCell Cycle by a Stable, Chromatin-Associated Retinoblastoma Tumor Suppressor Complex
    Bradley J. S. C. Olson, Michael Oberholzer, Yubing Li, James Matt Zones, Harjivan S. Kohli, Kateřina Bišová, Su‐Chiung Fang, Jill Meisenhelder, Tony R. Hunter, James Umen · 2010 · The Plant Cell
  95. Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2.
    M. Karin, D. Dhar · 2016 · Carcinogenesis
  96. Two Distinct E2F Transcriptional Modules Drive Cell Cycles and Differentiation
    Maria C. Cuitiño, Thierry Pécot, Daokun Sun, Raleigh D. Kladney, Takayuki Okano‐Uchida, Neelam Shinde, Resham Saeed, Antonio Perez-Castro, Amy Webb, Tom Liu et al. · 2019 · Cell Reports
  97. ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein
    Boulay, P-L, Schlienger, S, Lewis-Saravalli, S, Vitale, N, Ferbeyre, G, Claing, A · 2011 · Oncogene
  98. Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows
    Patrick J. Roberts, Vishnu Muthuraj Kumarasamy, Agnieszka Katarzyna Witkiewicz, Erik S. Knudsen · 2020 · Molecular Cancer Therapeutics
  99. RUNX2: A Master Bone Growth Regulator That May Be Involved in the DNA Damage Response
    Daniel Wysokiński, Elżbieta Pawłowska, Janusz Błasiak · 2015 · DNA and Cell Biology
  100. RETINOBLASTOMA-RELATED PROTEIN controls the transition to autotrophic plant development
    Ruben Gutzat, Lorenzo Borghi, Johannes Fütterer, Sylvain Bischof, Yec’han Laizet, Lars Hennig, Regina Feil, John Edward Lunn, Wilhelm Gruissem · 2011 · Development